Skip to main content
. 2022 Feb 9;12(3):e2517. doi: 10.1002/brb3.2517

TABLE 1.

Gender differences in quality of life in Parkinson's disease in the literature

Characteristic of the study sample
Study Region Sample size (M:F) Age, mean (SD) (M:F) Disease duration (years) H&Y/UPDRSIII HRQOL instrument Gender differences
(Abraham et al., 2019) The United States 1463 (914:549) 64.5 ± 10.4 vs 65.7 ± 11.0 n.a. 2.3 ± 0.8 vs. 2.4 ± 1.0/26.4 ± 12.4 vs. 26.3 ± 13.8 SF‐12 SF‐12 MH and SF‐12 PH: NS; females: less social support, more psychological distress, worse self‐reported disability (p < .05)
(Kim et al., 2019) Korea 100 (48:52) 57.3 ± 8.5 vs 60.2 ± 6.7 10.8 ± 4.0 vs. 12.0 ± 4.7 n.a./19.6 ± 11.9 vs. 19.4 ± 11.3 SF‐36 SF‐36 score: NS; Physical‐component summary and Mental‐component summary: NS
(Balash et al., 2019) Israel 122 68.3 ± 10.1 vs. 67.6 ± 7.7 Median: 8, IQR: 3–12 vs. median: 7.5, IQR: 3–12 Median: III, IQR: II–III/n.a. PDQ‐39 The PDQ‐39 SI scores were higher in female patients than in male patients. Mobility as well as emotional items and pain had a greater effect on women. Cognition and communication contribute to worsened QoL more in men than in women
(Yoon et al., 2017) Korea 89 (47:42) 68.18 ± 8.14 vs. 68.90 ± 7.71 2.6 ± 2.8 vs. 3.2 ± 3.6 2.1 ± 0.9 vs. 2.1 ± 0.9/24.2 ± 13.2 vs. 22.9 ± 12.9 PDQ‐39 The PDQ‐39 SI scores were higher in female patients than in male patients (p < .05)
(Dahodwala et al., 2016) Canada, the Netherlands, Israel, the United States 4679 (2938:1741) 65.5 ± 9.7 vs. 66.9 ± 9.7 8.7 ± 6.0 vs. 8.9 ± 6.6 Range: 1–5/n.a. PDQ‐39 The PDQ‐39 SI scores were higher in female patients than in male patients. Men reported lower QoL in mobility, emotional, and pain
Augustine et al., 2015 The United States and Canada 1738 (617:1121) n.a. 3.2 ± 2.0 vs. 3.3 ± 2.3 n.a./18.2 ± 8.2 vs. 17.0 ± 8.6 PDQ‐39 The PDQ‐39 SI scores were higher in female patients than in male patients
(Lubomski et al., 2014) Australia 210 (129:81) 70.1 ± 10.4 vs. 67.6 ± 11.3 7.4 ± 5.7 vs. 7.0 ± 5.8 n.a./27 ± 13 vs. 23 ± 13 PDQ‐39 The PDQ‐39 SI scores: NS. The PDQ‐39 showed men reported lower QoL in activities of daily living, cognition, and communication subscales (p < .05)
(Hristova et al., 2009) Bulgaria 866 (412:454) 74.0 ± 0.3 vs. 73.5 ± 0.4 6.7 ± 0.9 Range: 1−5/n.a. PDQ‐39 Significantly poorer QoL of women than men. Female PD patients: significantly worse assessment of QoL in aspects mobility, emotional well‐being, social support, and bodily discomfort
(Carod‐Artal et al., 2007) Brazilian 144 (77:67) 60 ± 11.4 vs. 64 ± 10.6 6.6 ± 3.8 Median: 2, IQR: 1.5−2.5/27.9 ± 14.5 PDQ‐39 The PDQ‐39 SI scores: NS; female: worse mobility, emotional well‐being, cognition, and bodily discomfort
(Moore et al., 2005) Israel 124 (69:55) 65.8 ± 10.2 8.5 ± 5.8 2.7 ± 0.9/48.4 ± 17.2 PDQ‐39 Significantly better QoL of PD women than PD men
(Behari et al., 2005) India 278 (218:60) 58.3 ± 10.5 vs. 53.1 ± 10.8 4.7 ± 3.8 vs. 4.4 ± 4.4 n.a./n.a. PDQL Women scored significantly lower on parkinsonian symptoms, systemic symptoms, social symptoms, emotional symptoms, and total score
(Kuopio et al., 2000) Finland 228 (104:124) 71.3 ± 9.5 vs. 73.4 ± 8.4 8.2 ± 5.1 vs. 9.5 ± 5.7 2.6 ± 0.9/n.a. SF‐36 Women scored significantly lower on five dimensions (physical functioning, role limitations—physical, social functioning, bodily pain, and mental health)

Abbreviations: n.a., not available; NS, not significant; M:F, MALE:FEMALE; PDQ‐39 SI, PDQ‐39‐Summary Index; PDQ‐39, PD Questionnaire‐39; PDQL, Parkinson disease quality of life questionnaire; SF‐12, 12‐Item Short Form Health Survey; SF‐36, 36‐Item Short Form Health Survey.